- Innovations in the fields of medicine and agricultural science / Cutting-edge technology for new cancer treatments / Integrated crop protection for global food security / Multimedia research: all topics also available in research online with additional videos, photo galleries and interactive infographics

Leverkusen, January 2015 – The latest, most fascinating findings from medical and agricultural research at Bayer are outlined in the new edition of research, the Bayer Scientific Magazine. The cover story, "Revolution in the plant kingdom," looks at tiny pests that have a huge impact. Scientists at Bayer CropScience from America, Europe and Asia are combating eelworms – nermatodes that cause enormous harvest losses all over the world. The researchers explain how they are getting to grips with this global problem by combining a completely new chemical principle with a biological agent. By using integrated crop protection in this way, they are helping to secure the global food supply.

Generating synergies to make life science research more efficient – that is what the special feature on "The protein engineers" is all about. Bayer's scientists working in medical and plant research are collaborating closely to develop new targets for active ingredients or diagnostic options, with innovative approaches ranging from the design of therapeutic antibodies through to improved production of new crop protection agents. Their work is focused on highly effective protein molecules that they construct for their specific purposes.

Readers can also find out more about 3D tumor screening in active substance research, new approaches for the treatment of wet age-related macular degeneration – an eye disease which leads to blindness if left untreated. Readers can also find out more about endometriosis, a disease that affects up to 10 percent of all women in child-bearing age and is associated with severe abdominal pain. Another article contains a fascinating report on Bayer's commitment to bee health.

The magazine's solidly researched, journalistic stories underline the company's mission, “Bayer: Science For A Better Life.” The publication spotlights the benefits of the latest developments, with informative graphics, attractive photos taken all over the world and supplementary interviews with renowned international scientists.

research, the Bayer scientific magazine, can be ordered free of charge by phone (+49 214/30-57546), fax (+49 214/30-57547) or e-mail (serviceline@bayer.com).

research online: research as a multimedia experience
research, the Bayer Scientific Magazine, is also available online: www.research.bayer.com brings the fascinating reports from the printed publication to life on PCs, tablets and smartphones. Attractive infographics, image galleries and videos give readers a comprehensive insight into the world of research at Bayer. They explain today's scientific challenges and outline the approaches being taken to resolve these issues.


Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2013, the Group employed 113,200 people and had sales of EUR 40.2 billion. Capital expenditures amounted to EUR 2.2 billion, R&D expenses to EUR 3.2 billion. For more information, go to www.bayer.com.
 
Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.